• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Intersection of glaucoma and retina at the pars plana

Video
Conferences|GLAUCOMA 360

J. Michael Jumper, MD, a retinal specialist at West Coast Retina (San Francisco, CA), discusses the highlights of his Glaucoma 360 presentation analyzing the impact and lasting effects of intraocular injections and retinal diseases in creating glaucoma as well as the evolving collaboration between retinal and glaucoma specialists.

See more Glaucoma 360 coverage

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
Ocugen completes dosing in second cohort of GARDian clinical trial for Stargardt disease

Ocugen completes dosing in second cohort of GARDian clinical trial for Stargardt disease

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
First patients treated in Phase 3 GLOW2 study of tarcocimab tedromer in diabetic retinopathy from Kodiak Sciences

First patients treated in Phase 3 GLOW2 study of tarcocimab tedromer in diabetic retinopathy from Kodiak Sciences

Article
Eyepod: Ocugen CEO gives update on OCU400

Eyepod: Ocugen CEO gives update on OCU400

Podcast
Study: CRISPR gene editing leads to improvements in vision for people with inherited blindness

Study: CRISPR gene editing leads to improvements in vision for people with inherited blindness

Article
Researchers: ‘Smart’ contact lenses may one day enable wireless glaucoma detection

Researchers: ‘Smart’ contact lenses may one day enable wireless glaucoma detection

Article
© 2024 MJH Life Sciences

All rights reserved.